Skip to main content

Find Clinical Trials

Home
Conditions
Depressive Disorder

Clinical trial condition

Depressive Disorder

Explore clinical trials studying Depressive Disorder. Study availability and eligibility vary by location and protocol.

2,784 public trials 426 recruiting studies

Refine in advanced search Browse all conditions

Depressive Disorder trial results

Recruiting

Repeated Real-time Biofeedback With 7-Tesla MRI for Treatment of Depression

NCT07694076

Conditions: Behavior, Behavioral Symptoms, Depression, +5 more
Locations: Oxford Centre for Integrative Neuroimaging (OxCIN) FMRIB, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital Oxford, United Kingdom

View Trial Details

Recruiting

Transcutaneous Auricular Neurostimulation (tAN) for Premenstrual Dysphoric Disorder (PMDD) and Perimenopause

NCT07688720

Conditions: Depressive Disorder, Menstruation Disturbances, Mental Disorders, +7 more
Locations: Texas Christian University Fort Worth, Texas, United States

View Trial Details

Recruiting

Vitamin B6 and Depression in Pregnant and Peri-partum Women

NCT06445933

Conditions: Depression, Postpartum, Depressive Disorder, Female Urogenital Diseases and Pregnancy Complications, +7 more
Locations: National Taiwan University Hospital Taipei, Taiwan

View Trial Details

Recruiting

EEG Prediction and Clinical Efficacy of tDCS in Major Depression

NCT07611773

Conditions: Depression - Major Depressive Disorder, Depressive Disorder, Depressive Disorder, Major, +2 more
Locations: Hospital Universiatrio Doctor Peset Valencia, Spain

View Trial Details

Recruiting

To Establish Whether Individuals With Premenstrual Dysphoric Disorder (PMDD) Demonstrate a Different Luteal-phase Sex Hormone Profile and Ratio Compared With Asymptomatic Controls.

NCT07686718

Conditions: Depressive Disorder, Menstruation Disturbances, Mental Disorders, +6 more
Locations: Lancaster University Lancaster, Lancashire, United Kingdom

View Trial Details

Recruiting

Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

NCT06547489

Conditions: Depressive Disorder, Depressive Disorder, Major, Major Depressive Disorder, +2 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

University of Alabama at Birmingham-Huntsville Huntsville, Alabama, United States

Wr-Pri, Llc Encino, California, United States

Irvine Clinical Research Irvine, California, United States

View all 34 locations

View Trial Details

Recruiting

Defining Neurobiological Links Between Substance Use and Mental Illness

NCT05538910

Conditions: Chemically-Induced Disorders, Depressive Disorder, Depressive Disorder, Major, +6 more
Locations: National Institute on Drug Abuse Baltimore, Maryland, United States

View Trial Details

Recruiting

Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression

NCT06480201

Conditions: Behavior, Behavioral Symptoms, Depression, +8 more
Locations: Wells Medicine Houston, Texas, United States

Texas A&M (Houston Methodist Hospital Location) Houston, Texas, United States

View Trial Details

Recruiting

A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder

NCT07227454

Conditions: Depressive Disorder, Depressive Disorder, Major, Mental Disorders, +1 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Peachford Hospital-Atlanta Behavioral Research Atlanta, Georgia, United States

Endeavor Health Evanston Hospital Evanston, Illinois, United States

University of Cincinnati Cincinnati, Ohio, United States

View all 30 locations

View Trial Details

Recruiting

An Open-Label Study to Evaluate the Safety, Tolerability and Pharmacodynamics of BPL-003 in Patients With Treatment Resistant Depression

NCT05660642

Conditions: Depressive Disorder, Depressive Disorder, Treatment-Resistant, Mental Disorders, +2 more
Locations: MAC Clinical Research Liverpool, United Kingdom

Hammersmith Medicines Research London, United Kingdom

King's College London, Clinical Trials Facility London, United Kingdom

View Trial Details